|
1
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Massagué J: TGF-beta signal transduction.
Annu Rev Biochem. 67:753–791. 1998.
|
|
3
|
Massagué J, Seoane J and Wotton D: Smad
transcription factors. Genes Dev. 9:2783–2810. 2005.PubMed/NCBI
|
|
4
|
Massagué J and Gomis RR: The logic of
TGFbeta signaling. FEBS Lett. 580:2811–2820. 2006.PubMed/NCBI
|
|
5
|
Taton M, Lamy F, Roger PP and Dumont JE:
General inhibition by transforming growth factor beta 1 of
thyrotropin and cAMP responses in human thyroid cells in primary
culture. Mol Cell Endocrinol. 95:13–21. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pekary AE and Hershman JM: Tumor necrosis
factor, ceramide, transforming growth factor-beta1, and aging
reduce Na+/I− symporter messenger ribonucleic
acid levels in FRTL-5 cells. Endocrinology. 139:703–712.
1998.PubMed/NCBI
|
|
7
|
Colletta G, Cirafici AM and Di Carlo A:
Dual effect of transforming growth factor beta on rat thyroid
cells: inhibition of thyrotropin-induced proliferation and
reduction of thyroid-specific differentiation markers. Cancer Res.
49:3457–3462. 1989.
|
|
8
|
Nicolussi A, D’Inzeo S, Santulli M,
Colletta G and Coppa A: TGF-beta control of rat thyroid follicular
cells differentiation. Mol Cell Endocrinol. 207:1–11. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costamagna E, García B and Santisteban P:
The functional interaction between the paired domain transcription
factor Pax8 and Smad3 is involved in transforming growth
factor-beta repression of the sodium/iodide symporter gene. J Biol
Chem. 279:3439–3446. 2004. View Article : Google Scholar
|
|
10
|
Morris JC 3rd, Ranganathan G, Hay ID,
Nelson RE and Jiang NS: The effects of transforming growth
factor-beta on growth and differentiation of the continuous rat
thyroid follicular cell line, FRTL-5. Endocrinology. 123:1385–1394.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coppa A, Mincione G, Mammarella S, Ranieri
A and Colletta G: Epithelial rat thyroid cell clones, escaping from
transforming growth factor beta negative growth control, are still
inhibited by this factor in the ability to trap iodide. Cell Growth
Differ. 6:281–290. 1995.PubMed/NCBI
|
|
12
|
Carneiro C, Alvarez CV, Zalvide J, Vidal A
and Domínguez F: TGF-beta1 actions on FRTL-5 cells provide a model
for the physiological regulation of thyroid growth. Oncogene.
16:1455–1465. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franzén A, Piek E, Westermark B, ten Dijke
P and Heldin NE: Expression of transforming growth factor-beta1,
activin A, and their receptors in thyroid follicle cells: negative
regulation of thyrocyte growth and function. Endocrinology.
140:4300–4310. 1999.PubMed/NCBI
|
|
14
|
Wyllie FS, Dawson T, Bond JA, Goretzki P,
Game S, Prime S and Wynford-Thomas D: Correlated abnormalities of
transforming growth factor-beta 1 response and p53 expression in
thyroid epithelial cell transformation. Mol Cell Endocrinol.
76:13–21. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Depoortere F, Pirson I, Bartek J, Dumont
JE and Roger PP: Transforming growth factor beta(1) selectively
inhibits the cyclic AMP-dependent proliferation of primary thyroid
epithelial cells by preventing the association of cyclin D3-cdk4
with nuclear p27(kip1). Mol Biol Cell. 11:1061–1076. 2000.
View Article : Google Scholar
|
|
16
|
Bornstein S, White R, Malkoski S, Oka M,
Han G, Cleaver T, Reh D, Andersen P, Gross N, Olson S, Deng C, Lu
SL and Wang XJ: Smad4 loss in mice causes spontaneous head and neck
cancer with increased genomic instability and inflammation. J Clin
Invest. 119:3408–3419. 2009.PubMed/NCBI
|
|
17
|
Ikushima H and Miyazono K: TGFβ
signalling: a complex web in cancer progression. Nat Rev Cancer.
10:415–424. 2010.
|
|
18
|
D’Inzeo S, Nicolussi A, Ricci A, Mancini
P, Porcellini A, Nardi F and Coppa A: Role of reduced expression of
SMAD4 in papillary thyroid carcinoma. J Mol Endocrinol. 45:229–244.
2010.PubMed/NCBI
|
|
19
|
Wikström P, Stattin P, Franck-Lissbrant I,
Damber JE and Bergh A: Transforming growth factor beta1 is
associated with angiogenesis, metastasis, and poor clinical outcome
in prostate cancer. Prostate. 37:19–29. 1998.PubMed/NCBI
|
|
20
|
Padua D and Massagué J: Roles of TGFbeta
in metastasis. Cell Res. 19:89–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Riesco-Eizaguirre G, Rodríguez I, De la
Vieja A, Costamagna E, Carrasco N, Nistal M and Santisteban P: The
BRAFV600E oncogene induces transforming growth factor beta
secretion leading to sodium iodide symporter repression and
increased malignancy in thyroid cancer. Cancer Res. 69:8317–8325.
2009. View Article : Google Scholar
|
|
22
|
D’Inzeo S, Nicolussi A, Donini CF, Zani M,
Mancini P, Nardi F and Coppa A: A novel human Smad4 mutation is
involved in papillary thyroid carcinoma progression. Endocr Relat
Cancer. 19:39–55. 2012.PubMed/NCBI
|
|
23
|
Dremier S, Coulonval K, Perpete S,
Vandeput F, Fortemaison N, Van Keymeulen A, Deleu S, Ledent C,
Clément S, Schurmans S, Dumont JE, Lamy F, Roger PP and Maenhaut C:
The role of cyclic AMP and its effect on protein kinase A in the
mitogenic action of thyrotropin on the thyroid cell. Ann NY Acad
Sci. 968:106–1021. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mincione G, Di Marcantonio MC, Tarantelli
C, D’Inzeo S, Nicolussi A, Nardi F, Donini CF and Coppa A: EGF and
TGF-β1 Effects on Thyroid Function. J Thyroid Res.
2011:4317182011.
|
|
25
|
Ambesi-Impiombato FS, Parks LA and Coon
HG: Culture of hormone-dependent functional epithelial cells from
rat thyroids. Proc Natl Acad Sci USA. 77:3455–3459. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schutte M, Hruban RH, Hedrick L, Cho KR,
Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H,
Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA and Kern SE: DPC4
gene in various tumor types. Cancer Res. 56:2527–2530.
1996.PubMed/NCBI
|
|
27
|
Nicolussi A, D’Inzeo S, Gismondi A and
Coppa A: Reduction of invasive potential in K-ras-transformed
thyroid cells by restoring of TGF-beta pathway. Clin Exp
Metastasis. 23:237–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lazzereschi D, Ranieri A, Mincione G,
Taccogna S, Nardi F and Colletta G: Human malignant thyroid tumors
displayed reduced levels of transforming growth factor beta
receptor type II messenger RNA and protein. Cancer Res.
57:2071–2076. 1997.
|
|
29
|
Medina DL and Santisteban P:
Thyrotropin-dependent proliferation of in vitro rat thyroid cell
systems. Eur J Endocrinol. 143:161–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kondo T, Ezzat S and Asa SL: Pathogenetic
mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer.
6:292–306. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang L, Duan CJ, Binkley C, Li G, Uhler
MD, Logsdon CD and Simeone DM: A transforming growth factor
beta-induced Smad3/Smad4 complex directly activates protein kinase
A. Mol Cell Biol. 24:2169–2180. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor beta in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lazzereschi D, Nardi F, Turco A, Ottini L,
D’Amico C, Mariani-Costantini R, Gulino A and Coppa A: A complex
pattern of mutations and abnormal splicing of Smad4 is present in
thyroid tumours. Oncogene. 24:5344–5354. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kimura T, Van Keymeulen A, Golstein J,
Fusco A, Dumont JE and Roger PP: Regulation of thyroid cell
proliferation by TSH and other factors: a critical evaluation of in
vitro models. Endocr Rev. 22:631–656. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ambesi-Impiombato FS, Picone R and
Tramontano D: Influence of hormones and serum on growth and
differentiation of the thyroid cell strain FRTL. Growth of Cells in
Hormonally Defined Media. 9. Sato GH, Pardee AB and Sirbaku DA:
Cold Spring Harbor; New York: pp. 483–492. 1982
|
|
36
|
Ambesi-Impiombato FS and Villone G: The
FRTL-5 thyroid cell strain as a model for studies on thyroid cell
growth. Acta Endocrinol Suppl (Copenh). 281:242–245.
1987.PubMed/NCBI
|
|
37
|
Veneziani BM, Di Marino C, Salvatore P,
Villone G, Perrotti N, Frunzio R and Tramontano D: Transfected
insulin-like growth factor II modulates the mitogenic response of
rat thyrocytes in culture. Mol Cell Endocrinol. 86:11–20. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takahashi S, Conti M and Van Wyk JJ:
Thyrotropin potentiation of insulin-like growth factor-I dependent
deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an
autocrine amplification factor(s). Endocrinology. 126:736–745.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tramontano D, Cushing GW, Moses AC and
Ingbar SH: Insulin-like growth factor-I stimulates the growth of
rat thyroid cells in culture and synergizes the stimulation of DNA
synthesis induced by TSH and Graves’-IgG. Endocrinology.
119:940–942. 1986.PubMed/NCBI
|
|
40
|
Koide T, Ono Y, Ito Y, Akahori M, Nedachi
T, Hakuno F, Takenaka A, Takahashi SI and Noguchi T: Insulin-like
growth factor-I potentiates protein synthesis induced by
thyrotropin in FRTL-5 cells: comparison of induction of protein
synthesis and DNA synthesis. Endocr J. 45:151–163. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Diehl JA: Cycling to cancer with cyclin
D1. Cancer Biol Ther. 1:226–231. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fu M, Wang C, Li Z, Sakamaki T and Pestell
RG: Minireview: Cyclin D1: normal and abnormal functions.
Endocrinology. 145:5439–5447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pickett CA, Agoff SN, Widman TJ and
Bronner MP: Altered expression of cyclins and cell cycle inhibitors
in papillary thyroid cancer: prognostic implications. Thyroid.
15:461–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Basolo F, Caligo MA, Pinchera A, Fedeli F,
Baldanzi A, Miccoli P, Iacconi P, Fontanini G and Pacini F: Cyclin
D1 overexpression in thyroid carcinomas: relation with
clinico-pathological parameters, retinoblastoma gene product, and
Ki67 labeling index. Thyroid. 10:741–746. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Khoo ML, Beasley NJ, Ezzat S, Freeman JL
and Asa SL: Overexpression of cyclin D1 and underexpression of p27
predict lymph node metastases in papillary thyroid carcinoma. J
Clin Endocrinol Metab. 87:1814–1818. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang S, Lloyd RV, Hutzler MJ, Safran MS,
Patwardhan NA and Khan A: The role of cell cycle regulatory
protein, cyclin D1, in the progression of thyroid cancer. Mod
Pathol. 13:882–887. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lazzereschi D, Sambuco L, Carnovale Scalzo
C, Ranieri A, Mincione G, Nardi F and Colletta G: Cyclin D1 and
Cyclin E expression in malignant thyroid cells and in human thyroid
carcinomas. Int J Cancer. 76:806–811. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Khoo ML, Ezzat S, Freeman JL and Asa SL:
Cyclin D1 protein expression predicts metastatic behavior in
thyroid papillary microcarcinomas but is not associated with gene
amplification. J Clin Endocrinol Metab. 87:1810–1813. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kang HC, Ohmori M, Harii N, Endo T and
Onaya T: Pax-8 is essential for regulation of the thyroglobulin
gene by transforming growth factor-beta1. Endocrinology.
142:267–275. 2001.PubMed/NCBI
|
